Browse
Submit Data
Databases
API
Help

Dataset Information

6 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Endoscopic Submucosal Dissection Registry

ABSTRACT: This is a patient registry for all cases of pre-neoplastic or early neoplastic digestive tract lesions treated with curative intention by endoscopic submucosal dissection (ESD) technique.

DISEASE(S): Esophageal Neoplasms,Duodenal Neoplasms,Neoplasm, Colorectal,Colorectal Neoplasms,Neoplasm, Esophagus,Neoplasm, Stomach,Stomach Neoplasms,Neoplasms,Neoplasm, Duodenal

PROVIDER: 91704 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

French Colorectal ESD Cohort in Experts Centers

Project description:Initially developed in Japan for the treatment of endemic superficial gastric cancers, endoscopic submucosal dissection (ESD) allows resection of pre-neoplastic and neoplastic lesions of the digestive tract into a single fragment. It allows a perfect pathological analysis, and decreases the rate of recurrence of the adenoma to less than 2%. However, this procedure, which is technically more challenging, is also more risky (perforation rate at 4% vs. 1% for WF-EMR) and longer. Submucosal dissection is also more expensive in terms of equipment, but this difference can be offset by the cost of the high number of iterative colonoscopies required in patients who have had endoscopic resection by WF-EMR. Scientific debate is agitating the Western world1,2 and Japanese experts do not perform WF-EMR anymore, whereas no comparative prospective study has compared these two procedures. A lot of centers in France performed colorectal ESD even for benign lesions and nationwide data about safety and efficiency is required to confirm the place of ESD for treatment of large superficial colorectal lesions.

| 2354874 | ecrin-mdr-crc

Brief Title : Optimized Endoscopic Submucosal Dissection With Snaring for Colorectal Neoplasm

Project description:This study is aimed to analyze the outcomes after conventional endoscopic submucosal dissection (ESD) and optimized ESD with snaring (oESD-S) for colorectal neoplasm that is more than 20 mm in diameter of laterllay spreading tumor or flat elevated lesion without stalk. Optimized ESD with snaring means submucosal dissection followed by snaring when narrowed circumference of the remained submucosal tissue beneath the lesion is less than 5 mm in diameter with snaring, then resected by using an electric current. The investigators expect optimized ESD with snaring can provide more time-saving procedure with comparable en-bloc resection rate and perforation rate, when compared with the conventional ESD method.

| 2151761 | ecrin-mdr-crc

Evaluation of the efficacy of motorized spiral enteroscope in colorectal endoscopic submucosal dissection (ESD) in cases with difficulty of intubation or poor maneuverability

Project description:Primary outcome(s): Completion rate of endoscopic submucosal dissection (ESD)

| 104537 | ecrin-mdr-crc

EndoscoPic Submucosal dIssection Using geL Versus glycerOl for Submucosal iNjection

Project description:The EPSILON study aims to comparatively evaluate the submucosal injection using ORISETM gel and glycerol during an ESD procedure in a specific population with superficial gastric and rectal (pre)neoplastic lesions.

| 2384495 | ecrin-mdr-crc

Breast Cancer Family Registry

Project description:Breast Cancer Family Registry

| PRJNA812673 | ENA

Breast Cancer Family Registry

Project description:Breast Cancer Family Registry

| PRJNA812674 | ENA

Prospective, Consecutive, Single-Center Study Western (Greek) Single-Center Experience of Endoscopic Submucosal Dissection (ESD) for Early Gastrointestinal Neoplasia. That is really possible in a Greek General Hospital.

Project description:Interventions: Endoscopic submucosal dissection (ESD) Primary outcome(s): Endoscopic ’en bloc’ and complete pathological R0 resection. Study Design: Single arm Non-randomized

| 2624630 | ecrin-mdr-crc

Prospective cohort study to evaluate the effectiveness, safety and long prognosis of endoscopic submucosal dissection for colorectal tumor

Project description:Interventions: Eendoscopic submucosal dissection for colorectal tumor Primary outcome(s): Prevalence of complete en bloc resection, complication and prognosis in patients with colorectal ESD Study Design: Single arm Non-randomized

| 2625546 | ecrin-mdr-crc

Endoscopic Sub-mucosal Dissection With the Nestis Jet Injector System With a Bi-functional Catheter: First Prospective Trial

Project description:ESD (Endoscopic Sub-mucosal Dissection)is the first-intent method to treat superficial neoplasms of the digestive tract at it allows an en-bloc R0 resection. Following marking of the lesion margins, ESD comprises 3 steps: 1) liquid injection into the sub-mucosal space 2) circumferential (complete or partial) incision and 3) dissection of the submucosa. Several tools are necessary to perform ESD with the standard technique. Development of water jet with bi functional (injection and cutting) catheter allows time and significant reduction of perforation risk (due to multiple changes of instruments). For this purpose, Nestis introduced the Enki 2 pulsed jet technology with high pressure system to inject efficiently and at any time viscous solutions in direct viewing and retroflexion. Preliminary pig studies indicate that injection of glycerol, hyaluronate and hydroxyethlstarch with Enki 2 are possible. In addition, preclinical studies on living pig colon models using saline solutions have demonstrated that perforation rates and operating times are significantly reduced compared to a standard electrosurgical knife. The present clinical study is being performed to confirm this system capability to perform ESD in humans.

| 2149365 | ecrin-mdr-crc

A randomized control trial of efficacy of endoscopic submucosal dissection using an ITknife nano for colorectal neoplasms larger than 30 mm in size

Project description:Interventions: Patients receive endoscopic submucosal dissection (ESD) for colorectal epitherial neoplasms. Primary outcome(s): Procedure time Study Design: randomized controlled trial, open(masking not used), active control, parallel assignment, treatment purpose

| 2612913 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data